BioSyent Inc. (TSXV:RX)
Canada · Delayed Price · Currency is CAD 14.44
+0.01 (0.07%)
May 15, 2026, 3:59 PM EST
BioSyent Market Cap
BioSyent has a market cap or net worth of CAD 165.17 million as of May 19, 2026. Its market cap has increased by 43.04% in one year.
Market Cap
165.17M
Enterprise Value
159.52M
Revenue
45.98M
Ranking
n/a
PE Ratio
18.42
Stock Price
14.44
Market Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 13.21M to 165.17M, an increase of 1,150.74%. That is a compound annual growth rate of 9.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 165.17M | 15.21% |
| Dec 31, 2025 | 143.37M | 12.27% |
| Dec 31, 2024 | 127.69M | 17.76% |
| Dec 29, 2023 | 108.44M | 28.05% |
| Dec 30, 2022 | 84.69M | -18.50% |
| Dec 30, 2021 | 103.91M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurora Cannabis | 270.21M |
| TerrAscend | 261.58M |
| Organigram Global | 208.14M |
| Cardiol Therapeutics | 202.49M |
| Auxly Cannabis Group | 200.54M |
| Cannara Biotech | 169.91M |
| HLS Therapeutics | 143.55M |
| Ascend Wellness Holdings | 128.53M |